Hírolvasó
Talking Tongues: New Lingual Frenulum Research Challenges Previous Beliefs
Antibodies Against SARS-CoV-2 in Human Milk: Milk Conversion Rates in the Netherlands
BackgroundIt has been demonstrated that human milk from mothers who have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contains antibodies against the virus, which could play an important role in protecting the recipient infant against coronavirus disease 2019 (COVID-19). Seroconversion is measured frequently around the world, but the milk conversion rate is unknown.Research AimsTo determine (1) the prevalence and (2) the dynamics of immunoglobulin A (IgA) antibodies against SARS-CoV-2 in human milk amongst lactating mothers in the Netherlands.MethodsIn this large prospective cohort study, lactating mothers (N = 2312) were included between October 12, 2020 and February 24, 2021. Enzyme-linked immunosorbent assay was used to determine levels of IgA antibodies in human milk and immunoglobulin G (IgG) antibodies in serum against the ectodomain of the SARS-CoV-2 spike protein.ResultsA total of 691 (30.6%) participants had SARS-CoV-2 specific antibodies in human milk and/or serum. Of these participants, 524 (23.1%) had IgA antibodies against SARS-CoV-2 in human milk, and 356 (15.7%) had IgG antibodies against SARS-CoV-2 in serum. A total of 199 (8.8%) participants had antibodies in both human milk and serum. SARS-CoV-2 specific IgA antibodies in human milk remain present at least 10 months after a polymerase chain reaction confirmed infection.ConclusionThe prevalence of IgA antibodies against SARS-CoV-2 in human milk was 23.1% in our cohort. This high prevalence of antibodies in human milk might lead to passive immunity in many breastfed infants and may serve as protection against COVID-19.
Realities and challenges of breastfeeding policy in the context of HIV: a qualitative study on community perspectives on facilitators and barriers related to breastfeeding among HIV positive mothers in Baringo County, Kenya
World Alliance for Breastfeeding Action (WABA) News
Achieving global targets on breastfeeding in Thailand: gap analysis and solutions
LEAARC News Brief
Watch Your Step
Breasts and the city: an urban ethnography of infant feeding in public spaces within Cardiff, United Kingdom
ILCA Board Nominations Now Open
The Effect of Holder Pasteurization on the Diversity of the Human Milk Bacterial Microbiota Using High-Throughput DNA Sequencing
BackgroundHuman milk is the best food for infants; however, when breastfeeding is not possible, pasteurized milk from human milk banks is the best alternative. Little has been reported about variations in the bacterial microbiota composition of human milk after pasteurization.Research aimTo characterize and compare the bacterial microbiota composition and diversity within human milk among Mexican mothers before and after the Holder pasteurization process.MethodsA cross-sectional, observational, and comparative design was used. The effect of the pasteurization process on the bacterial composition and diversity of human milk samples of donors (N = 42) from a public milk bank was assessed before and after pasteurization by high throughput deoxyribonucleic acid sequencing of V3-16S rRNA gene libraries. Sequencing data were examined using the Quantitative Insights into Microbial Ecology software and Phyloseq in R environment.ResultsA varied community of bacteria was found in both raw and pasteurized human milk. The bacterial diversity of the milk samples was increased by the pasteurization, where some thermoduric bacteria of the phyla Proteobacteria, Firmicutes, and Actinobacteria were more abundant. The source tracker analysis indicated that at most 1.0% of bacteria may have come from another source, showing the safety of the process used to treat milk samples.ConclusionThe pasteurization process increased the bacterial diversity. We selected taxa capable of surviving the process, which could proliferate after the treatment without being a risk for infants.
Beyond Borders: Creating Collaborations that Work
Three Continents, Two Fathers, One Donor: A Non-Puerperal Relactation Case Study
IntroductionA woman was able to relactate 7 years after breastfeeding her children. She donated her expressed milk to her friends, a same-sex male couple, who had a child through surrogacy in the United States. She lived in London and shipped her milk to Hong Kong, where they lived. The infant thrived on the donated expressed milk received during the first 3 months of his life.Main issueThis case is unusual because the woman was not breastfeeding at the time, which would have made expressing easier, and she was not adopting. She consulted a National Childbirth Trust Breastfeeding Counsellor and an International Board Certified Lactation Consultant® who helped her explore non-puerperal relactation protocols.ManagementHer plan started 6 months before the birth and included the use of domperidone, frequent expressing by hand and with a hospital-grade pump. A breastfeeding specialist physician made suggestions on the dosage of domperidone. She donated a total of 35.06 L. She had the full support of her partner and family.ConclusionNon-puerperal induced lactation and relactation offer ways to make human milk accessible to all infants, particularly those from LGBTQ+ families in which no parent is lactating, as was the case with the same-sex male couple participating in this study. It is essential to disseminate the knowledge and skills needed to support non-puerperal induced lactation and relactation among all healthcare professionals involved.
Prevalence and predictors of timely initiation of breastfeeding in Ghana: an analysis of 2017–2018 multiple indicator cluster survey
Impact of COVID-19 pandemic lockdown on exclusive breastfeeding in non-infected mothers
COVID-19 és várandósság, szoptatás, csecsemőkor
A COVID-19-fertőzést követően a tünetek elmúltával, illetve a védőoltás után nem szükséges késleltetni a gyermekvállalást, bármikor vállalható várandósság.
A várandósság önmagában nem jelent nagyobb veszélyt a koronavírus által történő megfertőződésre. Bár a legtöbb várandósnak fertőzés esetén csupán enyhe tünetei vannak, nagyobb számban alakulhatnak ki náluk - különösen a terhesség késői szakaszában - súlyos tünetek, mint a nem várandósoknál.
A várandósság alatt elszenvedett COVID-19 nem okoz magzati károsodást vagy vetélést. Ebben az esetben a magzat közvetve kerülhet veszélybe, ha az édesanyánál súlyos tünetek, pl. légzési elégtelenség jelentkeznek. Ilyen esetekben szükséges lehet a várandósság korai befejezése, az újszülött korai világra hozatala, mert ez biztosíthatja a legkedvezőbb kimenetelt mind az újszülött, mind az anya számára.
A cikk folytatása az Informed oldalán olvasható: COVID-19 és várandósság, szoptatás, csecsemőkor
judit 2021. 04. 16., p – 10:17 Tags Anya egészsége Várandósság Szoptatás CikkekCOVID-19 és várandósság, szoptatás, csecsemőkor
A COVID-19-fertőzést követően a tünetek elmúltával, illetve a védőoltás után nem szükséges késleltetni a gyermekvállalást, bármikor vállalható várandósság.
A várandósság önmagában nem jelent nagyobb veszélyt a koronavírus által történő megfertőződésre. Bár a legtöbb várandósnak fertőzés esetén csupán enyhe tünetei vannak, nagyobb számban alakulhatnak ki náluk - különösen a terhesség késői szakaszában - súlyos tünetek, mint a nem várandósoknál.
A várandósság alatt elszenvedett COVID-19 nem okoz magzati károsodást vagy vetélést. Ebben az esetben a magzat közvetve kerülhet veszélybe, ha az édesanyánál súlyos tünetek, pl. légzési elégtelenség jelentkeznek. Ilyen esetekben szükséges lehet a várandósság korai befejezése, az újszülött korai világra hozatala, mert ez biztosíthatja a legkedvezőbb kimenetelt mind az újszülött, mind az anya számára.
A cikk folytatása az Informed oldalán olvasható: COVID-19 és várandósság, szoptatás, csecsemőkor
judit 2021. 04. 16., p – 10:17 Tags Anya egészsége Várandósság Szoptatás